Threshold US · Senior housing

Nursing home supply in Nevada

66 certified nursing homes · 7,235 certified beds · CMS Care Compare
66
certified nursing homes
7,235
certified beds
110
average beds per home
3,248
beds in 1 or 2-star homes (at-risk supply)

CMS rating mix

Certified beds by CMS overall 5-star rating across Nevada. Beds in 1 and 2-star homes are supply that may not survive, and therefore latent replacement demand.

5-star934 beds
4-star1,832 beds
3-star1,101 beds
2-star2,062 beds
1-star1,186 beds
Not rated120 beds

Largest markets by beds

CityHomesBeds
Las Vegas302,981
Henderson51,008
Reno6744
North Las Vegas3610
Carson City4419
Sparks3341
Boulder City3314
Elko1146

Ownership

Ownership typeHomesBeds
For Profit - Limited Liability Company323,860
For Profit - Corporation202,335
For Profit - Individual3398
Government - State1180
For Profit - Partnership2174

Largest nursing homes

HomeCityBedsCMS rating
Henderson Health And RehabilitationHenderson2662-star
Tlc Care CenterHenderson2551-star
Oasis Nursing & Rehab Of Green ValleyHenderson2423-star
Mission Pines Nursing And Rehab CenterNorth Las Vegas2404-star
Royal Springs Healthcare And RehabLas Vegas2252-star
Life Care Center Of RenoReno1981-star
The Heights Of Summerlin, LlcLas Vegas1902-star
Alpine Skilled Nursing And Rehabilitation CenterReno1892-star

The demand gap

Coming shortly: the population aged 85+ in each catchment and the demand gap against the national rate, from US Census Bureau data (being finalized). Supply above is live now from CMS. Join the waitlist to be first in when the Nevada demand analysis goes live.

Appraise any Nevada site in 60 seconds

Threshold US Care is launching in 2026. Drop a pin anywhere in Nevada: every competing certified bed and its CMS rating, the demand gap, and the maximum land bid. Reserve founding access for Nevada now.

Join the Nevada waitlist

All states → · The US senior care gap →

Supply: CMS Care Compare Provider Information (public domain), latest release. Every figure is a statistical estimate for site screening, not a USPAP appraisal or investment advice.